Cystatin C measurements in the assessment of residual renal function, dialysis adequacy, and beyond

Peritoneal Dialysis International

Volumn 30, Issue 4, 2010, Pages 437-439

  Lindsay, Robert M ^a   Huang, Shih Han ^a   Filler, Guido ^b  

^a Department of Medicine   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEATH; EXTRACELLULAR SPACE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; JAPANESE; KIDNEY AGENESIS; KIDNEY CLEARANCE; KIDNEY FUNCTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; URINALYSIS;

CREATININE; CYSTATIN C; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS;

EID: 77957676763     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00136     Document Type: Article

References (13)

1. Adachi Y, Nishio A. A simple method to evaluate residual renal function by spot urinary cystatin C-to-creatinine ratio in peritoneal dialysis patients. Perit Dial Int 2010; 30:464-7.
2. Herget-Rosenthal S, van Wijk JA, Bröcker-Preuss M, Bökenkamp A. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem 2007; 40:946-51.
3. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002; 48:699-707.
4. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
5. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Carmerini C, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10:2295-305.
6. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA Study. J Am Soc Nephrol 2001; 12:2158-62.
7. Temorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-302.
8. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
9. Delaney MP, Stevens PE, Al Hasani M, Stowe HJ, Judge C, Lamb EJ. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross sectional study. Am J Kidney Dis 2008; 51:278-84.
10. Hoek FJ, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant 2007; 22:1633-8.
11. Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005; 38:1-8.
12. Al-Malki N, Heidenheim PA, Filler G, Yasin A, Lindsay RM. Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities. Clin J Am Soc Nephrol 2009; 4:1606-10.
13. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007; 147:19-27.